SGHT Q2 2023 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$23M+36.2% YoY

Gross Profit

$20M85.6% margin

Operating Income

-$15M-64.7% margin

Net Income

-$15M-62.9% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+24.7%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$185M

Total Liabilities

$49M

Stockholders' Equity

$136M

Cash & Equivalents

$155M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$17M	+36.2%
Gross Profit	$20M	$14M	+38.6%
Operating Income	-$15M	-$23M	+33.6%
Net Income	-$15M	-$24M	+38.1%

Revenue Segments

Surgical Glaucoma

$21M95%

Dry Eye

$1M5%